Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy
Paillasse, Michael R, Esquerré, Michael, Bertrand, Florie A, Poussereau-Pomié, Céline, Pichery, Mélanie, Visentin, Virgile, Gueguen-Dorbes, Geneviève, Gaujarengues, Florence, Barron, Pauline, Badet, Gaelle, Briaux, Anne, Ancey, Pierre-Benoit, Sibrac, David, Erdociain, Eric, Özcelik, Dennis, Meneyrol, Jérôme, Martin, Valérie, Gomez-Brouchet, Anne, Selves, Janik, Rochaix, Philippe, Battistella, Maxime, Lebbé, Céleste, Delord, Jean-Pierre, Dol-Gleizes, Frédérique, Bono, Françoise, Blanc, Isabelle, Alam, Antoine, Hunneyball, Ian, Whittaker, Mark, Fons, Pierre
Published in Cancer research communications (01.11.2022)
Published in Cancer research communications (01.11.2022)
Get full text
Journal Article
Dose and time dependencies of 5-fluorouracil pharmacokinetics
Terret, C, Erdociain, E, Guimbaud, R, Boisdron-Celle, M, McLeod, H L, Féty-Deporte, R, Lafont, T, Gamelin, E, Bugat, R, Canal, P, Chatelut, E
Published in Clinical pharmacology and therapeutics (01.09.2000)
Published in Clinical pharmacology and therapeutics (01.09.2000)
Get more information
Journal Article